These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34933212)

  • 1. Development of plant-made monoclonal antibodies against viral infections.
    Chen Q
    Curr Opin Virol; 2022 Feb; 52():148-160. PubMed ID: 34933212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Antibody Therapeutics against Flaviviruses.
    Sun H; Chen Q; Lai H
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies.
    Robak T; Robak E
    BioDrugs; 2011 Feb; 25(1):13-25. PubMed ID: 21090841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Monoclonal Antibody Produced in Glycoengineered Plants Potently Neutralizes Monkeypox Virus.
    Esqueda A; Sun H; Bonner J; Lai H; Jugler C; Kibler KV; Steinkellner H; Chen Q
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
    Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity.
    Dent M; Hurtado J; Paul AM; Sun H; Lai H; Yang M; Esqueda A; Bai F; Steinkellner H; Chen Q
    J Gen Virol; 2016 Dec; 97(12):3280-3290. PubMed ID: 27902333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies for prophylactic and therapeutic use against viral infections.
    Both L; Banyard AC; van Dolleweerd C; Wright E; Ma JK; Fooks AR
    Vaccine; 2013 Mar; 31(12):1553-9. PubMed ID: 23370150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of highly and broad-range specific monoclonal antibodies against hemagglutinin of H5-subtype avian influenza viruses and their differentiation by mass spectrometry.
    Sączyńska V; Bierczyńska-Krzysik A; Cecuda-Adamczewska V; Baran P; Porębska A; Florys K; Zieliński M; Płucienniczak G
    Virol J; 2018 Jan; 15(1):13. PubMed ID: 29334981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of monoclonal antibodies for the treatment of Ebola virus disease.].
    Sizikova TE; Borisevich GV; Shcheblyakov DV; Burmistrova DA; Lebedev VN
    Vopr Virusol; 2018; 63(6):245-249. PubMed ID: 30641019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts via Aqueous Two-Phase Separation.
    Jugler C; Joensuu J; Chen Q
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The growth and potential of human antiviral monoclonal antibody therapeutics.
    Marasco WA; Sui J
    Nat Biotechnol; 2007 Dec; 25(12):1421-34. PubMed ID: 18066039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoengineered antibodies: towards the next-generation of immunotherapeutics.
    Mastrangeli R; Palinsky W; Bierau H
    Glycobiology; 2019 Mar; 29(3):199-210. PubMed ID: 30289453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation.
    Mimura Y; Saldova R; Mimura-Kimura Y; Rudd PM; Jefferis R
    Exp Suppl; 2021; 112():481-517. PubMed ID: 34687020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections.
    Keeler SP; Fox JM
    Viruses; 2021 May; 13(6):. PubMed ID: 34072720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential requirements for FcγR engagement by protective antibodies against Ebola virus.
    Bournazos S; DiLillo DJ; Goff AJ; Glass PJ; Ravetch JV
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20054-20062. PubMed ID: 31484758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
    Tshiani Mbaya O; Mukumbayi P; Mulangu S
    Front Immunol; 2021; 12():721328. PubMed ID: 34526994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.
    Mokhtary P; Pourhashem Z; Mehrizi AA; Sala C; Rappuoli R
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.
    Van den Hoecke S; Ehrhardt K; Kolpe A; El Bakkouri K; Deng L; Grootaert H; Schoonooghe S; Smet A; Bentahir M; Roose K; Schotsaert M; Schepens B; Callewaert N; Nimmerjahn F; Staeheli P; Hengel H; Saelens X
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections.
    Boonyaratanakornkit J; Boeckh M; Waghmare A
    Curr Opin Infect Dis; 2022 Aug; 35(4):280-287. PubMed ID: 35849517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Detailed Protocol for Generation of Therapeutic Antibodies with Galactosylated Glycovariants at Laboratory Scale Using In-Vitro Glycoengineering Technology.
    Voruganti S; Xu J; Li X; Balakrishnan G; Singh SM; Kar SR; Das TK
    J Pharm Sci; 2021 Feb; 110(2):935-945. PubMed ID: 33039440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.